Peter Ewald

Peter Ewald

Auto-generated profile, based on publicly available information

Peter Ewald

St. Josef-Hospital Bochum, Ruhr University Bochum, Germany

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 July 2026 in Endoscopy
Verified
Journal Article
Open access
MAMousa Ayoub
Mousa Ayoub
EKEsma Z. Kızılaslan
Esma Z. Kızılaslan
SNSandra Nagl
Sandra Nagl
FAFatih Aslan
Fatih Aslan
TBTorsten Beyna
Torsten Beyna
AEAlanna Ebigbo
Alanna Ebigbo
Endoscopic closure techniques are essential for management of endoscopic defects and help prevent delayed bleeding and perforation. This study reports clinical outcomes of an endoscopic hand-suturing system (EHS) for defect closure. This multicenter European registry study evaluated all procedures using EHS from 14 centers. The primary end point was technical success, defined as complete defect closure without additional closure techniques. Secondary end points were in-hospital clinical success (absence of post-interventional complications), overall defect closure rate (closure achieved with additional devices), and suturing speed. Between February 2023 and January 2026, 338 procedures were included. Indications comprised endoscopic submucosal dissection (n = 240), endoscopic intermuscular dissection (n = 32), gastric peroral endoscopic myotomy (n = 41), fistula (n = 10), endoscopic mucosal resection (n = 6), submucosal tunneling endoscopic resection (n = 3), nonexposed endoscopic wall inversion surgery (n = 2), and anastomotic leak, perforation, endoscopic full-thickness resection, and endoscopic hemostasis (all n = 1). Median defect size was 35 mm (range 4–155 mm) and median suturing time was 25 minutes (range 4–120). Technical success was 96.2% (325/338). Overall defect closure rate was 96.7% (327/338). In-hospital clinical success was 97.9% (331/338). Defect size did not predict suturing time in the size-adjusted model, indicating that procedural complexity was not explained by size alone. Procedure-related adverse events occurred in 5/338 (1.5%); overall adverse event rate was 10/338 (3.0%). EHS demonstrated high technical and in-hospital clinical success with a low short-term adverse event rate. Further studies are needed to assess performance with complex defects.

13 January 2026 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
OCOscar Cahyadi
Oscar Cahyadi
CRChristian Torres Reyes
Christian Torres Reyes
MAMousa Ayoub
Mousa Ayoub
DQDaniel Quast
Daniel Quast
PEPeter Ewald
Peter Ewald
AEAlanna Ebigbo
Alanna Ebigbo
Third-space endoscopy, including peroral endoscopic myotomy (POEM) and endoscopic submucosal dissection (ESD), has become an established therapeutic option for various gastrointestinal disorders. A newly developed slim therapeutic gastroscope aims to improve maneuverability and provide easier access to the submucosal space and also to enhance ergonomic aspects of tedious therapeutic procedures. The aim of this study (The Slim Scop3 Trial) was to evaluate the subjective workload and usability of the novel slim therapeutic gastroscope during third space procedures. Secondary outcomes included technical and clinical performance as well as adverse events (AEs). This was a prospective, single-arm, single-center study comprising 30 patients undergoing third-space endoscopy in a high-volume center in Germany. Subjective workload and usability were assessed with the NASA-Task load index (NASA-TLX) and the System Usability Score (SUS), respectively. Clinical outcomes and AEs were recorded prospectively. The slim gastroscope showed a low NASA-TLX and high SUS score, which correlates with a low subjective workload and high usability. POEM showed a tendency toward lower NASA-TLX and higher SUS compared with ESD. For ESD, the en-bloc and curative R0 resection rate was 100%. No device-related AE events occurred. A novel slim gastroscope offers high usability with a low subjective workload for third space procedures. The slim gastroscope has the potential to reduce ergonomic strain on endoscopists during complex therapeutic interventions.

13 January 2026 in Endoscopy International Open
Verified
Journal Article
Open access
PDF file
PEPeter Ewald
Peter Ewald
OCOscar Cahyadi
Oscar Cahyadi
CZChristoph Zeidler
Christoph Zeidler
MTMax Tophof
Max Tophof
MAMousa Ayoub
Mousa Ayoub
AEAlanna Ebigbo
Alanna Ebigbo
Background Endoscopic vacuum therapy (EVT) is a minimally invasive therapy for managing transmural gastrointestinal defects and supports the control of local infection. The role of EVT in patients with infected walled-off necrosis (WON) resulting from acute necrotizing pancreatitis (ANP) has not yet been investigated. Methods A multicenter retrospective case analysis was conducted. Patients with infected WON due to severe ANP (Revised Atlanta Classification) in whom the standard step-up therapy was expanded to include EVT, were identified and included in the study. Results Sixteen patients (aged 22–81 years) were treated in addition to standard therapy with EVT in four tertiary care centers in Germany and Brazil. After a total of 108 EVT device exchanges, the clinical success (sepsis control, complete resolution of WON, and closure of fistula) was achieved in 14 of 16 patients. Two patients died as a direct result of ANP and WON, while one further patient died of pneumosepsis after complete resolution of WON. Intracavitary bleeding occurred during device exchange in two patients, corresponding to a per-procedure bleeding rate of 1.9%. Conclusions Intracavitary EVT is feasible and relatively safe in treating patients with WON. Larger prospective trials are necessary to evaluate a potential adjunctive benefit of EVT in this challenging patient cohort.

13 January 2026 in Endoscopy International Open
Verified
Journal Article
Open access
OCOscar Cahyadi
Oscar Cahyadi
AEAlanna Ebigbo
Alanna Ebigbo
CRChristian Torres Reyes
Christian Torres Reyes
AZAntonia Zörb
Antonia Zörb
ETElena Theiß
Elena Theiß
PEPeter Ewald
Peter Ewald
Background Workflow interruptions are common in procedural medicine and may increase cognitive load, stress, and the risk of errors. While interruptions and flow disruptions have been studied in surgical settings, little is known about workflow interruptions in endoscopic environments. Objective evaluation of workflow interruptions requires a reliable measurement tool. This study aimed to develop a structured observation tool for recording workflow interruptions during endoscopic procedures and to evaluate its interrater reliability. Methods A structured tally-based observation tool for recording workflow interruptions was developed in an iterative process, and interruptions were categorized into predefined domains. Three independent observers underwent structured training and calibration. A predefined subset of endoscopic procedures was observed simultaneously by two independent observers. Interrater reliability was assessed using intraclass correlation coefficients (ICCs) and Bland–Altman analysis. Results A total of 35 procedures were scheduled for double observation, and 33 procedures were included in the final interrater reliability analysis. Interrater reliability for the total number of interruptions was excellent for both observer pairs (ICC 0.995 for A–B and 0.995 for A–C). Reliability across interruption domains ranged from good to excellent. Bland–Altman analysis demonstrated small mean differences with narrow limits of agreement and no relevant systematic bias. Conclusion This methodologic study demonstrates that workflow interruptions during endoscopic procedures can be measured reliably using a structured tally-based observation tool. The instrument provides a standardized methodologic framework for future studies investigating workflow processes and workflow-focused interventions in endoscopy.